
Pharmapacks, once the world’s largest Amazon reseller, collapsed due to an unsustainable business model characterized by massive domestic overhead and razor-thin margins. Despite securing hundreds of millions in private equity funding from the Carlyle Group, the company failed to achieve profitability, recording losses exceeding $100 million annually by 2021. A failed attempt to go public via a SPAC during shifting market conditions ultimately triggered bankruptcy in 2022. The company’s assets were subsequently liquidated for $2 million to its former president, who transitioned the entity into a third-party logistics provider known as Packable. This trajectory illustrates the inherent risks of high-overhead reselling in the Amazon ecosystem and demonstrates how struggling e-commerce brands sometimes pivot to service-oriented models to survive. Modern sellers must prioritize lean operations and lower overhead to remain competitive as margins continue to compress.
Sign in to continue reading, translating and more.
Open full episode in Podwise